These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35568033)

  • 1. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
    Nick JA; Dedrick RM; Gray AL; Vladar EK; Smith BE; Freeman KG; Malcolm KC; Epperson LE; Hasan NA; Hendrix J; Callahan K; Walton K; Vestal B; Wheeler E; Rysavy NM; Poch K; Caceres S; Lovell VK; Hisert KB; de Moura VC; Chatterjee D; De P; Weakly N; Martiniano SL; Lynch DA; Daley CL; Strong M; Jia F; Hatfull GF; Davidson RM
    Cell; 2022 May; 185(11):1860-1874.e12. PubMed ID: 35568033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
    Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785625
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriophage infection and killing of intracellular
    Schmalstig AA; Wiggins A; Badillo D; Wetzel KS; Hatfull GF; Braunstein M
    mBio; 2024 Jan; 15(1):e0292423. PubMed ID: 38059609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Dedrick RM; Smith BE; Cristinziano M; Freeman KG; Jacobs-Sera D; Belessis Y; Whitney Brown A; Cohen KA; Davidson RM; van Duin D; Gainey A; Garcia CB; Robert George CR; Haidar G; Ip W; Iredell J; Khatami A; Little JS; Malmivaara K; McMullan BJ; Michalik DE; Moscatelli A; Nick JA; Tupayachi Ortiz MG; Polenakovik HM; Robinson PD; Skurnik M; Solomon DA; Soothill J; Spencer H; Wark P; Worth A; Schooley RT; Benson CA; Hatfull GF
    Clin Infect Dis; 2023 Jan; 76(1):103-112. PubMed ID: 35676823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
    Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
    Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.
    Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL
    Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus.
    Johansen MD; Alcaraz M; Dedrick RM; Roquet-Banères F; Hamela C; Hatfull GF; Kremer L
    Dis Model Mech; 2021 Sep; 14(9):. PubMed ID: 34530447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.
    Dedrick RM; Guerrero-Bustamante CA; Garlena RA; Russell DA; Ford K; Harris K; Gilmour KC; Soothill J; Jacobs-Sera D; Schooley RT; Hatfull GF; Spencer H
    Nat Med; 2019 May; 25(5):730-733. PubMed ID: 31068712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapulmonary Treatment with Mycobacteriophage LysB Rapidly Reduces Mycobacterium abscessus Burden.
    Hurst-Hess K; Walz A; Yang Y; McGuirk H; Gonzalez-Juarrero M; Hatfull GF; Ghosh P; Ojha AK
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0016223. PubMed ID: 37154689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.
    Monin L; Mehta S; Elsegeiny W; Gopal R; McAleer JP; Oury TD; Kolls J; Khader SA
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263106
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Degiacomi G; Sammartino JC; Chiarelli LR; Riabova O; Makarov V; Pasca MR
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 14. The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission.
    Dedrick RM; Abad L; Storey N; Kaganovsky AM; Smith BE; Aull HA; Cristinziano M; Morkowska A; Murthy S; Loebinger MR; Hatfull GF; Satta G
    Clin Microbiol Infect; 2023 Oct; 29(10):1335.e9-1335.e16. PubMed ID: 37364635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities.
    Amarh ED; Dedrick RM; Garlena RA; Russell DA; Gauthier CH; Aull HG; Abad L; Jacobs-Sera D; Akusobi C; Rubin EJ; Hatfull GF
    PLoS One; 2023; 18(2):e0281769. PubMed ID: 36795728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice.
    Tissot A; Thomas MF; Corris PA; Brodlie M
    BMC Pulm Med; 2018 May; 18(1):86. PubMed ID: 29788939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for Phage Therapy Against
    Senhaji-Kacha A; Esteban J; Garcia-Quintanilla M
    Front Microbiol; 2020; 11():609017. PubMed ID: 33537013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Recchia D; Stelitano G; Stamilla A; Gutierrez DL; Degiacomi G; Chiarelli LR; Pasca MR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.